4.2 Review

Systemic loxoscelism induced warm autoimmune hemolytic anemia: clinical series and review

Journal

HEMATOLOGY
Volume 27, Issue 1, Pages 543-554

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/16078454.2022.2065086

Keywords

Systemic loxoscelism; Loxoscelism; Anemia; Hemolytic anemia; warm autoimmune hemolytic anemia; Spider; brown recluse; envenomation

Categories

Ask authors/readers for more resources

This study describes two cases of warm autoimmune hemolytic anemia (AIHA) caused by systemic loxoscelism. The patients developed symptomatic anemia after being bitten by a brown recluse spider, and were subsequently diagnosed with warm AIHA. Treatment with corticosteroids, aggressive intravenous fluid hydration, and packed red blood cell transfusion led to clinical improvement and eventual discharge.
Objectives Describe the development of warm autoimmune hemolytic anemia warm (AIHA) secondary to a brown recluse spider (Loxosceles reclusa) bite is known as systemic loxoscelism; and review epidemiology, clinical manifestations, diagnostic work-up, pathophysiology, and treatment options associated with warm AIHA secondary to systemic loxoscelism. Methods Cases series of two cases of warm AIHA due to systemic loxoscelism and a review of the current literature: epidemiology, clinical manifestations, diagnostic work-up, pathophysiology, and treatment options associated with warm AIHA secondary to systemic loxoscelism. Results Presented here are two cases of warm AIHA due to systemic loxoscelism. Each patient was generally healthy appearing and presented with symptomatic anemia in the setting of brown recluse spider bites. Both patients were eventually found to have warm AIHA. Upon recognition of the diagnosis, the patients were started on corticosteroids and aggressive intravenous fluid hydration. In addition, they received transfusions of packed red blood cells. Their clinical courses improved, and they recovered to eventually be discharged home. Conclusion Envenomation by a brown recluse spider, Loxosceles reclusa, can result in systemic loxoscelism which can cause warm AIHA. The diagnosis of warm AIHA is confirmed by the direct antiglobulin/Coomb's test. Warm AIHA can be a life-threatening disease process. Hemodynamic support with intravenous fluids and RBC transfusion is the initial step in the management of these patients. Corticosteroids are the mainstay of current management. Second line treatments include rituximab. Rarely patients require splenectomy for refractory disease. Corticosteroids should be tapered over a three-month period.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available